Welldoc Introduces AI-Powered Cardiometabolic Care for Medicare Beneficiaries
Welldoc announced its selection by CMS to participate in the ACCESS Model, targeting cardiometabolic health for Medicare beneficiaries. The company will focus on the CKM and eCKM tracks, providing AI-driven solutions for patients with diabetes, obesity, and hypertension.
COLUMBIA, Md.–(BUSINESS WIRE)–Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced it has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model. Welldoc will participate in both the Cardio-Kidney-Metabolic (CKM) and Early CKM (eCKM) tracks, bringing its AI-driven clinical platform to Medicare beneficiaries living with diabetes, obesity, hypertension, a